Seminars in Radiation Oncology
Volume 19, Issue 2 , Pages 87-95 , April 2009

Radiosensitivity of Cancer-Initiating Cells and Normal Stem Cells (or what the Heisenberg Uncertainly Principle has to do with Biology)

  • Wendy Ann Woodward

      Affiliations

    • Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
    • Corresponding Author InformationAddress reprint requests to Wendy Woodward, Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Box 1202, 1515 Holcombe Blvd, Houston, TX 77005
    • ,
  • Robert Glen Bristow

      Affiliations

    • Radiation Medicine Program, Princess Margaret Hospital (University Health Network) and Departments of Radiation Oncology and Medical Biophysics, University of Toronto, Toronto, Canada

References 

  1. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer. 2003;3:895–902
  2. Potten C. Radiation, the ideal cytotoxic aged for studying the cell biology of tissues such as the small intestine. Rad Res. 2004;161:123–136
  3. Bentzen SM. Steepness of the radiation dose-response curve for dose-per-fraction escalation keeping the number of fractions fixed. Acta Oncol. 2005;44:825–828
  4. Bentzen SM. Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nat Rev Cancer. 2006;6:702–713
  5. Bentzen SM, Trotti A. Evaluation of early and late toxicities in chemoradiation trials. J Clin Oncol. 2007;25:4096–4103
  6. Deacon J, Peckham MJ, Steel GG. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol. 1984;2:317–323
  7. Bristow RG, Hill RP. Comparison between in vitro radiosensitivity and in vivo radio response in murine tumor cell lines (II: In vivo radio response following fractionated treatment and in vitro/in-vivo correlations). Int J Radiat Oncol Biol Phys. 1990;18:331–345
  8. Geara F, Girinski TA, Chavaudra N, et al. Estimation of clonogenic cell fraction in primary cultures derived from human squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 1991;21:661–665
  9. West CM. Invited review: Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Br J Radiol. 1995;68:827–837
  10. Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer. 2008;8:545–554
  11. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444:756–760
  12. Hill RP, Milas L. The proportion of stem cells in murine tumors. Int J Radiat Oncol Biol Phys. 1989;16:513–518
  13. Taghian A, Suit H, Pardo F, et al. In-vitro intrinsic radiation sensitivity of glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 1992;23:55–62
  14. Brock WA, Baker FL, Wike JL, et al. Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control. Int J Radiat Oncol Biol Phys. 1990;18:1283–1286
  15. Dontu G, Abdallah WM, Foley JM, et al. In-vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003;17:1253–1270
  16. Yu F, Yao H, Zhu P, et al. Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 2007;131:1109–1123
  17. Shackleton M, Vaillant F, Simpson KJ, et al. Generation of a functional mammary gland from a single stem cell. Nature. 2006;439:84–88
  18. Stingl J, Eirew P, Ricketson I, et al. Purification and unique properties of mammary epithelial stem cells. Nature. 2006;439:993–997
  19. Welm B, Behbod F, Goodell MA, et al. Isolation and characterization of functional mammary gland stem cells. Cell Prolif. 2003;36(suppl 1):17–32
  20. Welm BE, Tepera SB, Venezia T, et al. SCA-1(Pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol. 2002;245:42–56
  21. Hirschmann-Jax C, Foster AE, Wulf GG, et al. A distinct “side population” of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A. 2004;101:14228–14233
  22. Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A. 2004;101:781–786
  23. Zhou S, Morris JJ, Barnes Y, et al. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc Natl Acad Sci U S A. 2002;99:12339–12344
  24. Woodward WA, Chen MS, Behbod F, et al. Wnt/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci U S A. 2007;104:618–623
  25. Phillips TM, McBride WH, Pajonk F. The response of CD24(−/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst. 2006;98:1777–1785
  26. Kang M, Hur B, Ko M, et al. Potential identity of multi-potential cancer stem-like subpopulation after radiation of cultured brain glioma. BMC Neurosci. 2008;9:1–12
  27. Hambardzumyan D, Becher OJ, Rosenblum MK, et al. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev. 2008;22:436–448
  28. Chiou S, Kao C, Chen Y, et al. Identification of CD133− positie radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS ONE. 2008;3:1–13
  29. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100:3983–3988
  30. Durand RE, Olive PL. Resistance of tumor cells to chemo- and radiotherapy modulated by the three-dimensional architecture of solid tumors and spheroids. Methods Cell Biol. 2001;64:211–233
  31. Park CC, Zhang H, Pallavicini M, et al. Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res. 2006;66:1526–1535
  32. Zhang M, Behbod F, Atkinson RL, et al. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res. 2008;68:4674–4682
  33. Reynolds BA, Rietze RL. Neural stem cells and neurospheres—Re-evaluating the relationship. Nat Methods. 2005;2:333–336
  34. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 1992;255:1707–1710
  35. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396–401
  36. Potten C, Booth C, Tudor G, et al. Identification of a putative instestinal stem cell and early lineage marker; Musashi-1. Differentiation. 2003;71:28–41
  37. Sureban S, May R, George R, et al. Knockdown of RNA binding protein Musashi-1 leads to tumor regression in Vivo. Gastroenterology. 2008;134:1448–1458
  38. Klopp A, Spaeth E, Dembinski J, et al. Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res. 2007;67:11687–11695
  39. Kiltie AE, Orton CJ, Ryan AJ, et al. A correlation between residual DNA double-Strand breaks and clonogenic measurements of radiosensitivity in fibroblasts from preradiotherapy cervix cancer patients. Int J Radiat Oncol Biol Phys. 1997;39:1137–1144
  40. Klokov D, MacPhail SM, Banath JP, et al. Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays. Radiother Oncol. 2006;80:223–229
  41. Zaffaroni N, Orlandi L, Villa R, et al. DNA double-strand break repair and radiation response in human tumour primary cultures. Int J Radiat Biol. 1994;66:279–285
  42. Bristow RG, Ozcelik H, Jalali F, et al. Homologous recombination and prostate cancer: A model for novel DNA repair targets and therapies. Radiother Oncol. 2007;83:220–230
  43. Liu SK, Olive PL, Bristow RG. Biomarkers for DNA DSB inhibitors and radiotherapy clinical trials. Cancer Metastasis Rev. 2008;27:445–458
  44. Kastan MB. DNA damage responses: Mechanisms and roles in human disease: 2007 G (HA Clowes memorial award lecture). Mol Cancer Res. 2008;6:517–524
  45. Eyler CE, Rich JN. Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol. 2008;26:2839–2845
  46. Liu S, Ginestier C, Charafe-Jauffret E, et al. BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci U S A. 2008;105:1680–1685
  47. Niedernhofer LJ. DNA repair is crucial for maintaining hematopoietic stem cell function. DNA Repair (Amst). 2008;7:523–529
  48. Nijnik A, Woodbine L, Marchetti C, et al. DNA repair is limiting for haematopoietic stem cells during ageing. Nature. 2007;447:686–690
  49. Rossi DJ, Bryder D, Seita J, et al. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature. 2007;447:725–729
  50. Chan N, Milosevic M, Bristow RG. Tumor hypoxia, DNA repair and prostate cancer progression: New targets and new therapies (Future). Oncol. 2007;3:329–341
  51. Bristow RG, Hill RP. Hypoxia and metabolism (Hypoxia, DNA repair and genetic instability). Nat Rev Cancer. 2008;8:180–192
  52. Rodriguez-Jimenez FJ, Moreno-Manzano V, Lucas-Dominguez R, et al. Hypoxia causes Down-regulation of mismatch repair system and genomic instability in stem cells. Stem Cells. 2008;
  53. Chen MF, Lin CT, Chen WC, et al. The sensitivity of human mesenchymal stem cells to ionizing radiation. Int J Radiat Oncol Biol Phys. 2006;66:244–253
  54. Tichy ED, Stambrook PJ. DNA repair in murine embryonic stem cells and differentiated cells. Exp Cell Res. 2008;314:1929–1936
  55. Maynard S, Swistikowa AM, Lee JW, et al. Human embryonic stem cells have enhanced repair of multiple forms of DNA damage. Stem Cells. 2008;
  56. Banuelos CA, Banath JP, Macphail SH, et al. Mouse but not human embryonic stem cells are deficient in rejoining of ionizing radiation-induced DNA double-strand breaks. DNA Repair (Amst). 2008;7:1471–1483
  57. Nieder C, Andratschke N, Astner ST. Experimental concepts for toxicity prevention and tissue restoration after central nervous system irradiation. Radiol Oncol. 2007;2:23
  58. Lombaert IM, Brunsting JF, Wierenga PK, et al. Rescue of salivary gland function after stem cell transplantation in irradiated glands. PLos ONE. 2008;3(4):e2063
  59. Lombaert IM, Wierenga PK, Kok T, et al. Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands. Clin Cancer Res. 2006;12(6):1804–1812
  60. Verheij M. Clinical biomarkers and imaging for radiotherapy-induced cell death. Cancer Metastasis Rev. 2008;27:471–480
  61. Blazek ER, Foutch JL, Maki G. Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133− cells, and the CD133+ sector is enlarged by hypoxia. Int J Radiat Oncol Biol Phys. 2007;67:1–5
  62. Platet N, Mayol JF, Berger F, et al. Fluctuation of the SP/non-SP phenotype in the C6 glioma cell line. FEBS Lett. 2007;581:1435–1440
  63. Arbab AS, Janic B, Knight RA, et al. Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings. FASEB J. 2008;
  64. Chen MS, Woodward WA, Behbod F, et al. Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line. J Cell Sci. 2007;120:468–477

PII: S1053-4296(08)00079-9

doi: 10.1016/j.semradonc.2008.11.003

Seminars in Radiation Oncology
Volume 19, Issue 2 , Pages 87-95 , April 2009

Article Tools

* Image Usage & Resolution